Loading provider…
Loading provider…
Ophthalmology Physician in Mountain View, CA
NPI: 1053306381Primary Employer
Northern California Retina Vitreous Associates Medical Group, Inc.
ncrva.com
HQ Phone
Get MD James's Phone NumberMobile
Get MD James's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1994 - 2027
MA State Medical License
1996 - 1999

American Board of Ophthalmology
Ophthalmology
Stanford University School Of Medicine
med.stanford.edu
Medical School
Until 1992
Massachusetts Eye and Ear Infirmary/Harvard Medical School
Fellowship • Surgical Retina and Vitreous
1996 - 1998
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes
Residency • Ophthalmology
1993 - 1996
St Mary's Hospital and Medical Center
Internship • Internal Medicine
1992 - 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 875 | 2,429 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 497 | 509 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 383 | 602 |
| 4 | 67028Injection of drug into eye | 378 | 1,581 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 327 | 558 |
Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study.
Authors: James Palmer, Mark Wieland, Louis Chang
Publication Date: 2018-12-16
Dexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetes.
Authors: James Palmer, Mark Wieland, Rahul Khurana
Journal: Ophthalmic Surg Lasers Imaging Retina
THE ASSOCIATION OF EPIRETINAL MEMBRANE WITH MACULAR HOLE FORMATION AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR.
Authors: Tien Wong, Eric Chen, James Palmer, Louis Chang, James Major, Rahul Khurana, Alok Bansal, Charles Wykoff
Publication Date: 2017-06
Lead Sponsor: Northern California Retina Vitreous Associates
Intervention / Treatment: PROCEDURE: Intravitreal Injection of sulfahexafluoride gas
Lead Sponsor: Regeneron Pharmaceuticals
Collaborators: Bayer
Intervention / Treatment: DRUG: High-dose aflibercept, DRUG: aflibercept